
Orchestra BioMed 10% owner Rtw Investments Lp buys $6.0 million of shares
Open market purchase reported on Form 4, filed Nov 12, 2026.
Snapshot
Rtw Investments Lp, a holder of more than 10% of the shares of Orchestra BioMed (OBIO), bought 1,200,000 shares in open market purchases on Nov 9, 2026, about $6.0 million at an average price of $5.00 a share, according to a Form 4 filed with the SEC on Nov 12, 2026.
- Independent Research
Market Data
| Company | 1D % | Price |
|---|---|---|
| ($OBIO) | ▲ +4.52% | 7.29 |
as of 09:57 ET · Realtime derived data
What We Know
The filing lists 1 open market purchase line: • Nov 9, 2026: 1,200,000 shares at $5.00.
After the last purchase, the filing reports 10,756,063 shares held indirectly in that account.
Octans View
The purchases raised the holding reported in that account by about 13%, computed from the filed share counts. An open market purchase is made with the insider's own money at the market price, unlike option exercises or stock awards, which this brief excludes. The filing does not say why the insider bought. The filing is a joint filing with 1 related reporting person; the purchases are counted once.
Bear Case · Room for Disagreement
Limits. Insiders must report trades within two business days; this brief covers one filing and does not net it against sales by the same person or other insiders. Prices are as filed; where a line shows a weighted average, the filing's footnotes give the range.
Method and source. Octans Research reads the structured Form 4 filed with the SEC, keeps open market purchases (code P) only, and computes the total value and the average price from the filed share counts and prices. The filed price must sit within 25% of the closing price on the trade date. The text is generated by a fixed template; no model wrote it.
Chart
Sources
- [1]SEC EDGAR — Form 4 filed by Rtw Investments Lp for Orchestra BioMed, Nov 12, 2026
These are the sources this piece was drafted from. How we verify. Found an error? Tell us and we correct it in public.
$6.0M
More on $OBIO
4 reports
Clearone 10% owner First Finance Ltd. buys $756,000 of shares
Open market purchase reported on Form 4, filed Nov 17, 2026.
Neostellar Capital CEO Mark D Klein buys $994,000 of shares
Open market purchase reported on Form 4, filed Nov 16, 2026.
Affiliated Managers director G. Staley Cates buys $1.0 million of shares
Open market purchase reported on Form 4, filed Nov 16, 2026.
BrightSpire Capital CEO Michael Mazzei buys $1.0 million of shares
Open market purchase reported on Form 4, filed Nov 16, 2026.